Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Radiosurgery × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 24 Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 17 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 9 Melanoma 6 Breast Neoplasms 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 3 Liver Neoplasms 3 Urinary Bladder Neoplasms 2 NSCLC 2 Kidney Neoplasms 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Unresectable Locally Recurrent Rectal Cancer 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Stage II Prostate Adenocarcinoma AJCC v7 1 Spinal Cord Neoplasms 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1

Interventions

Specimen Handling 6 Cyclophosphamide 6 Temozolomide 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 fludarabine 4 X-Rays 4 Phantoms, Imaging 4 Doxorubicin 4 dinutuximab 3 cabozantinib 3 Vincristine 3 Methotrexate 3 Irinotecan 3 Ifosfamide 3 Gemcitabine 3 Cisplatin 3 olaparib 2 mifamurtide 2 ivosidenib 2 irinotecan sucrosofate 2 ensartinib 2 atezolizumab 2 Zoledronic Acid 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Nuclear Medicine Department, Hospital 2 Etoposide 2 Eflornithine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06492954 2026-03-02

AflacST2301

Emory University

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡